When the same drug, medical device, chemical, product, or business practice allegedly hurts a large number of people, the legal system has to deal with a problem that one ordinary lawsuit cannot easily handle.
That is where mass-tort litigation comes into play.
Rather than forcing every plaintiff and every lawyer to repeat the same discovery, scientific arguments, depositions, and factual investigations, courts can coordinate cases that share important facts. The people bringing those claims, however, generally remain individuals with their own lawsuits.
That distinction is easy to miss. It also explains much of how mass-tort litigation works.
A large mass tort can involve thousands of plaintiffs, major corporations, insurers, law firms, expert witnesses, litigation funders, and years of court proceedings. Some cases settle. Some are dismissed. Others may eventually go to individual trials.
Here is what happens inside that process, how an MDL fits into it, why a mass tort is not the same as a class action, and why a settlement’s headline dollar figure does not tell the whole story.
AI Overview
Mass-tort litigation brings together large numbers of individual lawsuits that share a common source of alleged harm, such as a drug, medical device, product, chemical, or business practice. An MDL can coordinate those cases in federal court, but it doesn’t turn them into one lawsuit or make them a class action. Each plaintiff generally keeps an individual claim, with factors such as injury, causation, exposure, and damages still mattering.
Key Takeaways
- Mass torts involve individual claims. Many people may sue over the same alleged harm, but their cases don’t automatically become one lawsuit.
- An MDL coordinates cases. It brings lawsuits with common factual issues together for much of the pretrial work under 28 U.S.C. § 1407.
- MDL and class actions aren’t the same. Class actions follow Federal Rule of Civil Procedure 23, while MDLs generally coordinate separate lawsuits.
- Bellwether trials can shape negotiations. Early cases may be selected to test evidence and litigation risk, but their results don’t automatically decide other plaintiffs’ claims.
- Settlement amounts vary. A large headline settlement doesn’t mean every claimant gets the same payment. Eligibility, evidence, injury, fees, expenses, liens, and settlement rules can all affect the final recovery.
- Advertising isn’t proof of a claim. A mass-tort advertisement doesn’t establish liability or guarantee compensation.
- The numbers can get huge. The federal MDL system had 197,115 pending actions across 158 MDL dockets as of October 1, 2025.
- Your individual facts still matter. Exposure, medical records, timing, causation, damages, and the specific court orders governing the litigation can determine whether your claim qualifies.
What Is Mass-Tort Litigation?
Mass-tort litigation involves numerous individual legal claims connected to the same alleged source of harm.
The connection could be a prescription drug, medical device, consumer product, chemical exposure, environmental event, or alleged business practice. The plaintiffs may have experienced similar injuries, but their circumstances are rarely identical.
One person may have a different medical history. Another may have had a different level or duration of exposure. Their diagnoses, treatment, financial losses, and evidence of causation can vary substantially.
So a mass tort is not simply one giant lawsuit with thousands of names attached to it.
In most cases, each claimant keeps an individual claim. What changes is how the courts handle the common issues. Instead of repeating the same work in thousands of separate proceedings, related cases may be coordinated so that shared discovery and other pretrial matters can be handled more efficiently.
You may see several terms used for these proceedings:
- Mass tort
- Mass-injury litigation
- Aggregate litigation
- Product-liability mass tort
- Toxic-tort litigation
- MDL litigation
- Coordinated proceeding
- JCCP in some state court systems
There is one distinction worth keeping straight: an MDL is not another name for every mass tort.
Multidistrict litigation, or MDL, is a specific federal procedure used to coordinate civil cases that involve common factual questions. A mass tort can exist without being handled through an MDL.
How Does Mass-Tort Litigation Work?
Most mass torts begin with a suspected pattern of harm.
Sometimes the warning signs come from safety research or adverse-event reports. In other situations, a recall, regulatory action, government investigation, internal company documents, a court verdict, or evidence of chemical exposure brings the issue into public view.
Law firms then begin investigating the potential claims.
That investigation can be extensive. Lawyers may look at the product involved, when and how a person was exposed, medical diagnoses, medical records, potential causation evidence, jurisdiction, statutes of limitation, available insurance, and the defendant’s financial ability to satisfy potential claims.
Then comes claimant intake.
Potential clients can find law firms through television commercials, search advertising, social media, law-firm websites, referrals, co-counsel relationships, and legal lead vendors. Intake teams screen those people and collect documents that may help determine whether their claims fit the litigation.
Once lawsuits are filed, related federal cases may be transferred into an MDL when the requirements for coordinated proceedings are met.
The court can then organize common discovery, document production, depositions, expert disputes, and recurring legal questions. That can remove a huge amount of duplicated work.
Eventually, some cases may be selected as bellwethers.
These early cases give both sides an opportunity to see how evidence performs in front of a jury and to assess the risks of taking similar claims to trial. A bellwether verdict, however, does not automatically determine what happens to every other plaintiff.
After that, the litigation can move in several directions. Cases may settle, be dismissed, proceed to individual trials, or be sent back to the courts where they were originally filed.
What Is an MDL?
An MDL, or multidistrict litigation, is a federal procedure used to coordinate civil cases that share one or more common factual questions.
Congress created the federal MDL system in 1968 through 28 U.S.C. § 1407.
The reasoning behind the procedure is fairly practical. If thousands of lawsuits involve the same product, company documents, executives, scientific evidence, and underlying conduct, requiring every courtroom to repeat that work separately can create enormous duplication.
An MDL allows a federal court to centralize much of that pretrial work.
But centralization does not turn every lawsuit into one giant case.
The individual lawsuits generally remain separate. Plaintiffs continue to have their own claims, injuries, evidence, and damages. That becomes particularly important in personal-injury litigation, where two people exposed to the same product may have very different medical histories and outcomes.
Mass Tort vs. Class Action: What’s the Difference?
Mass torts and class actions are often mentioned together because both can involve large numbers of people.
Legally, though, they work differently.
| Feature | Mass Tort / MDL | Class Action |
| Structure | Separate individual cases coordinated for pretrial work | One case brought by representative plaintiffs for a certified class |
| Personal injury | Usually evaluated individually | Can be difficult when injuries and causation vary significantly |
| Federal procedure | MDL transfer can occur under 28 U.S.C. § 1407 | Certification is governed by Rule 23 |
| Plaintiff control | Each plaintiff generally maintains an individual lawsuit | Class members may be bound by the result depending on the class |
| Main purpose | Coordinate common discovery and legal issues | Resolve claims that can be handled on a common class-wide basis |
Class actions have their own legal requirements.
Under Federal Rule of Civil Procedure 23, a proposed class must satisfy requirements that include numerosity, commonality, typicality, and adequate representation. For certain damages classes, common questions must also predominate, and the class action must be superior to other available methods of resolving the dispute.
That can become difficult when plaintiffs’ circumstances vary sharply.
Consider a case involving alleged personal injuries. One plaintiff might have a documented diagnosis and years of treatment, while another may have a different diagnosis, different exposure history, or a different medical background. Trying to resolve all of those questions through one class-wide proceeding can be complicated.
Mass-tort litigation provides a different structure because individual claims generally remain individual claims even when common issues are coordinated.
Why Do Courts Use MDLs?
The simple answer is efficiency.
Picture thousands of lawsuits involving the same product. Each one could require evidence from the same company, testimony from the same executives, scientific research involving the same product, and arguments concerning the same alleged conduct.
Repeating that process thousands of times would consume enormous amounts of court and party resources.
MDL coordination allows common factual issues to be investigated together. It can also reduce the risk that different courts will reach inconsistent pretrial decisions on the same underlying questions.
That does not mean an MDL guarantees a settlement.
Some proceedings continue for years. Individual claims can be dismissed. Others can settle. Some may eventually go to trial, while eligible cases can be returned to the courts where they were originally filed.
An MDL is a method of managing litigation. It is not a promise about the outcome.
How Big Is the MDL System?
The numbers show just how large coordinated litigation can become.
According to the U.S. Judicial Panel on Multidistrict Litigation, there were 158 pending MDL dockets containing 197,115 pending actions as of October 1, 2025.
The cases were heavily concentrated in a relatively small group of proceedings. The Panel reported that 23 MDLs with at least 1,000 pending actions accounted for 185,600 cases, representing 94.16% of all pending MDL actions.
One docket shows the scale particularly well.
The federal Johnson & Johnson talc MDL had 67,204 pending actions on October 1, 2025.
These statistics cover the MDL system as a whole, rather than only personal-injury mass torts. Even so, they make one thing clear: a small number of enormous proceedings account for a substantial share of the federal MDL caseload.
What Happens During an MDL?
An MDL can involve years of legal and scientific work before individual cases are resolved.
Common discovery
The parties exchange documents, take depositions, collect evidence, and investigate the allegations.
When thousands of lawsuits involve the same underlying facts, much of that discovery can be conducted on a coordinated basis rather than repeated independently in every case.
Expert evidence
Scientific and medical evidence often becomes one of the most heavily contested parts of a mass tort.
Depending on the case, experts may address exposure, medical causation, product design, warnings, toxicology, epidemiology, or the alleged injuries.
Both sides can challenge opposing experts and the methods used to reach their conclusions. Those disputes can have a major effect on whether particular claims can move forward.
Bellwether trials
The court may select a limited number of cases for early trials.
These cases are not supposed to decide everyone else’s claims. Their purpose is to show both sides what a trial involving similar allegations may look like, including how evidence is received by a jury and what litigation risks the parties face.
The results can affect settlement negotiations.
A bellwether verdict does not, by itself, establish liability or damages for every plaintiff in the MDL.
Settlement negotiations
If the parties eventually reach a settlement, the agreement can be far more complicated than the dollar figure announced in a press release.
Settlement programs can contain eligibility rules, payment categories, scoring systems, documentation requirements, lien procedures, releases, and administrative requirements.
That is why the headline number tells only part of the story.
How Do Mass-Tort Settlements Work?
A settlement does not necessarily mean every claimant receives the same payment.
First, the claim generally has to qualify under the settlement’s rules. Those rules may examine medical records, exposure history, product identification, diagnosis, timing, and other evidence.
Once eligibility is established, claims may be divided into different categories or payment tiers.
The amount can then be affected by other deductions.
Depending on the particular case, those deductions may include attorney fees, litigation expenses, medical liens, taxes in some circumstances, and financing obligations.
The result is an important distinction between gross settlement value and individual net recovery.
A settlement advertised as being worth billions of dollars does not mean each claimant receives a simple share of that number.
The actual amount reaching a particular plaintiff depends on the settlement structure and that person’s claim.
Who Is Involved in a Mass Tort?
A large mass tort involves far more people than just plaintiffs and defendants.
| Participant | Role in the process |
| Claimants | Provide evidence of exposure, injury, losses, and eligibility |
| Plaintiff law firms | Investigate, finance, file, and litigate claims |
| Lead generators | Help firms identify potential claimants |
| Advertisers | Promote legal services and generate inquiries |
| Co-counsel and referral firms | Refer cases or share legal work under applicable rules |
| Defendants | Defend claims and negotiate settlements |
| Insurers | May provide coverage or participate in resolving claims |
| Litigation funders | Provide capital under financing arrangements in some cases |
| Courts | Manage proceedings and rule on legal disputes |
| Plaintiff leadership | Coordinates common litigation work where appointed |
| Settlement administrators | Verify claims and calculate distributions |
These participants do not all have the same interests.
Plaintiff firms, for example, can spend significant amounts investigating and litigating claims before they receive any payment. If claims fail or clients are disqualified, the firm may not recover those investments through a successful contingency fee.
That financial reality is one reason claimant screening and case administration matter so much in large litigation.
Why Are There So Many Mass-Tort Advertisements?
The advertising is not accidental.
A large litigation needs a way to identify people who may have relevant claims. Law firms can use television commercials, search advertising, social media, websites, referrals, co-counsel arrangements, and specialized legal lead-generation companies to reach potential clients.
But there is a line that should not be blurred:
An advertisement is not proof of liability.
Seeing a television commercial does not mean a court has found a company responsible. It does not prove that a particular person has a valid claim, and it does not guarantee compensation.
Advertising can sometimes make developing litigation appear more settled than it actually is.
There is another issue. Large-scale lead generation can produce weak, duplicate, time-barred, or medically unsupported claims alongside legitimate ones. Screening those files takes time and money, and poor-quality claims can add administrative pressure to an already complicated proceeding.
What Are the Benefits of Mass-Tort Litigation?
Coordination is the biggest practical advantage.
When thousands of cases involve overlapping facts, centralized discovery can reduce duplicated work. Courts can also address common legal and factual issues without requiring every judge to start from scratch.
There is another difference from a certified class action: individual plaintiffs generally retain their own claims.
That matters when injuries and damages are not identical.
Settlement programs can also make it possible to resolve large numbers of eligible claims through a structured process rather than requiring every dispute to proceed through a separate full trial.
The outcome depends on how the litigation and settlement are structured. Eligibility rules, claimant representation, settlement terms, administration, and court oversight can all affect what happens next.
What Are the Problems With Mass-Tort Litigation?
Mass-tort litigation is not a shortcut around proving a claim.
A plaintiff may still need evidence of exposure, injury, causation, and damages. Coordination does not eliminate those individual requirements.
There is also the problem of claim volume. Advertising and large-scale intake can bring in people whose claims ultimately do not satisfy the litigation’s requirements.
Then there is time.
Mass torts can last for years because discovery, expert challenges, bellwether trials, appeals, settlement negotiations, and individual proceedings all take time.
Another common source of confusion is settlement value. The amount announced publicly may be dramatically different from what an individual claimant eventually receives after eligibility rules, payment formulas, attorney fees, expenses, liens, and other deductions are considered.
And an MDL should not be treated as a class action simply because many plaintiffs are being handled together. The legal structures are different.
What Are the Biggest Mass-Tort Areas?
Several major categories appear in current public records.
Talc litigation remains one of the largest examples by pending federal actions. The Johnson & Johnson talc MDL had 67,204 pending actions as of October 1, 2025.
Hernia-mesh litigation is another major category. The Judicial Panel reported 24,004 pending actions in the Davol/C.R. Bard polypropylene hernia-mesh MDL on that same date.
PFAS litigation covers a much broader range of disputes, including personal-injury claims, environmental cases, municipal claims, and other legal actions.
Roundup litigation continues to involve significant settlement and legal issues. Meanwhile, social-media youth-harm litigation represents a newer category involving technology companies.
The phrase “biggest mass tort” needs some caution, though.
Pending case counts, settlement values, advertising activity, and potential corporate exposure measure different things. A proceeding with the most lawsuits is not automatically the one with the largest settlement or greatest financial exposure.
What Can Recent Cases Teach You?
Recent litigation shows how differently mass torts can develop.
In February 2026, Bayer proposed a $7.25 billion nationwide Roundup settlement covering tens of thousands of current and future lawsuits. As of August 26, 2026, the proposal was still awaiting court action, with a Missouri hearing scheduled for September 14, 2026.
Roundup also demonstrates how a single legal development can change the litigation landscape. On June 25, 2026, the U.S. Supreme Court ruled for Monsanto in Durnell, limiting certain state-law failure-to-warn claims involving Roundup.
PFAS litigation provides another example of the financial scale involved in environmental disputes. On August 7, 2026, a federal judge approved more than $2.5 billion in settlements involving New Jersey and DuPont, Chemours, Corteva, and 3M.
That proceeding involved government environmental claims, so it should not be treated as identical to a personal-injury mass tort. It does, however, show how large PFAS-related legal exposure can become.
Technology litigation is evolving as well.
Reuters reported a $6 million Meta and Google verdict in March 2026 involving allegations of social-media harm to young people. The case was described as a bellwether for similar litigation.
Again, the result of one bellwether does not automatically determine the outcome of every other case.
Practical Guide: What Should You Check Before Joining a Mass Tort?
If a law firm contacts you about a mass tort, or you find the firm through an advertisement—do not rush through the paperwork.
Start by finding out exactly what you are signing.
Ask whether the firm has actually filed your case and whether it will handle the litigation itself. If another firm is involved, find out whether the first firm is referring the claim or acting as co-counsel.
The financial terms deserve the same attention.
You should understand the contingency-fee percentage, when litigation expenses are deducted, who is responsible for those expenses if the case does not succeed, and whether other costs could reduce your recovery.
Medical and exposure requirements matter, too. Ask what documentation the firm needs and how it will evaluate your records.
It is also worth asking how the firm will keep you informed and whether you have the right to reject a proposed settlement.
Most of all, read the retainer agreement before signing it. The document controls many of the practical details of the attorney-client relationship.
Here are the basic questions to have answered:
- Has the firm actually filed your case?
- Is the firm lead counsel, or is it referring your claim elsewhere?
- How does the contingency fee work?
- When are litigation costs deducted?
- Who pays expenses if the case does not succeed?
- What medical or exposure evidence is required?
- How will the firm communicate with you?
- Can you reject a proposed settlement?
- Could attorney liens or other fee disputes affect your recovery?
- What does the retainer agreement actually say?
A television commercial or online intake form is not a guarantee of compensation.
Whether someone qualifies depends on the facts of that person’s claim and the rules governing the particular litigation.
Common Mistakes People Make
One of the easiest mistakes is calling an MDL a class action.
They are different.
Another mistake is assuming that the number of people advertised by a law firm represents the number of valid claims. A firm’s inventory may include files still undergoing screening. It is not automatically the same as the number of filed cases or successful claims.
Settlement figures create another misunderstanding.
A billion-dollar settlement does not mean every claimant receives a large payment. Individual recoveries can depend on eligibility, injury severity, supporting documentation, payment formulas, attorney fees, litigation expenses, liens, and other deductions.
There is also a tendency to assume that being part of a large litigation means the outcome is already known.
It isn’t.
Mass torts can change direction as courts rule on evidence, experts, legal theories, settlements, and individual claims.
The Bottom Line on Mass-Tort Litigation
A person watching a mass-tort advertisement might imagine one enormous lawsuit with thousands of people standing together against one company.
The legal reality is much more fragmented.
Mass-tort litigation starts with individual claims and uses coordination to deal with the facts those claims have in common. An MDL can make common discovery and pretrial proceedings more manageable, but it does not erase the differences between plaintiffs.
The numbers can be staggering. As of October 1, 2025, the federal MDL system had 197,115 pending actions, and just 23 MDLs with at least 1,000 cases accounted for 185,600 of them.
Still, the size of a docket does not tell you whether an individual claim is valid. Nor does a large settlement headline tell you what a particular plaintiff will ultimately receive.
That distinction is worth keeping in mind whenever the advertisements start piling up.
A mass tort is a legal process.
It is not a promise of payment.
Frequently Asked Questions
What is the difference between a mass tort and a class action?
A mass tort generally consists of many individual plaintiffs with separate claims, while a class action uses representative plaintiffs to pursue a certified class. Mass-tort cases may be coordinated through an MDL, but each claimant generally maintains an individual lawsuit. Class actions must satisfy the requirements of Federal Rule of Civil Procedure 23.
Is an MDL the same as a mass tort?
No. An MDL is a federal procedure established under 28 U.S.C. § 1407 for coordinating cases that involve common factual questions. Many mass torts use MDLs, but an MDL can also involve disputes that are not traditional personal-injury mass torts.
How do mass-tort lawyers get paid?
Many plaintiff firms work under contingency-fee agreements, meaning their compensation is generally tied to a recovery instead of an hourly fee. The percentage charged, treatment of litigation expenses, liens, and other costs depend on the written agreement and applicable law.
Do mass-tort settlements guarantee money for every claimant?
No. Settlement programs can impose specific eligibility, medical, exposure, timing, and documentation requirements. Even eligible claimants may receive different amounts depending on the settlement structure and deductions that apply to their claims.
How long does a mass-tort case take?
There is no standard timeline. Discovery, expert disputes, bellwether trials, appeals, settlement negotiations, and individual proceedings can cause a mass tort to continue for years.
What is a bellwether trial?
A bellwether trial is an early case selected from a larger coordinated group to test evidence and help both sides assess litigation risk. Its verdict can influence settlement negotiations, but it does not automatically decide the claims of every other plaintiff.
Can I join an MDL without filing my own lawsuit?
An MDL normally consists of individual civil actions, so participation generally requires a lawsuit or another court-approved process. The exact procedure depends on the particular docket, court orders, settlement terms, and applicable law.
Why are there so many mass-tort advertisements?
Large litigation requires firms to identify and screen potential claimants. Law firms can use television advertising, search advertising, social media, websites, referrals, co-counsel arrangements, and legal lead vendors to find people who may have relevant claims.
Does a mass-tort advertisement mean a company has been found liable?
No. An advertisement is not a court judgment or scientific finding. Liability, causation, damages, and claimant eligibility still have to be established through litigation or a negotiated settlement.
What does mass-tort inventory mean?
Mass-tort inventory generally refers to claimant files or cases held or represented by a law firm, group of firms, or another participant in the litigation. It does not automatically mean every file represents a valid claim or a person who will receive compensation.
Who pays for mass-tort settlements?
Depending on the case, defendants may pay directly, use insurance, establish settlement funds, make structured payments, or use several funding sources. The exact arrangement depends on the settlement agreement, insurance coverage, corporate finances, and applicable court orders.
Are litigation funders the same as law firms?
No. A law firm represents its clients, while a litigation funder provides capital under a financing arrangement. Funding agreements can involve different costs, disclosure requirements, and ethical restrictions depending on the jurisdiction and contract.
